ALRPRB.PFD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ALRPRB.PFD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Alere's Cash per Share for the quarter that ended in Jun. 2017 was $0.00.
The historical data trend for Alere's Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alere Annual Data | |||||||||||||||||||||
Trend | Dec07 | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | |||||||||||
Cash per Share | Get a 7-Day Free Trial | - | - | - | - | - |
Alere Quarterly Data | ||||||||||||||||||||
Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | |
Cash per Share | Get a 7-Day Free Trial | - | - | - | - | - |
This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.
Alere's Cash per Share for the fiscal year that ended in Dec. 2016 is calculated as:
Cash per Share | = | Cash, Cash Equivalents, Marketable Securities | / | Shares Outstanding (EOP) |
= | 567.291 | / | 0.00 | |
= | N/A |
Alere's Cash per Share for the quarter that ended in Jun. 2017 is calculated as:
Cash per Share | = | Cash, Cash Equivalents, Marketable Securities | / | Shares Outstanding (EOP) |
= | 491.849 | / | 0.00 | |
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alere (NYSE:ALRPRB.PFD) Cash per Share Explanation
Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.
Thank you for viewing the detailed overview of Alere's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
John Bridgen | officer: Sr VP, Business Development | 51 SAWYER ROAD, C/O INVERNESS MEDICAL INNOVATIONS INC, WALTHAM MA 02453 |
Geoffrey S Ginsburg | director | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Renuka Uppaluri | officer: Senior VP, Global R&D | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Mark Gladwell | officer: Senior VP, Global Operations | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Gregg J Powers | director | C/O QUANTUM CORPORATION, 224 AIRPORT PARKWAY SUITE 300, SAN JOSE CA 95110 |
Jonathan Wygant | officer: VP, Controller, CAO | 3750 TORREY VIEW COURT, SAN DIEGO X1 92130 |
Thomas Mckillop | director | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Melissa Guerdan | officer: SVP, Global Quality & Reg. | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Daniella Cramp | officer: Global Pres., Cardiometabolic | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Sanjay Malkani | officer: Global Pres., Toxicology | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
James Jr. Roosevelt | director | 51 SAWYER ROAD, SUITE 200, HOPKINTON MA 02453 |
Robert Bernard Hargadon | officer: SVP, Global Human Resources | 4327 LAKE WASHINGTON BLVD NE #6208, KIRKLAND WA 98033 |
John F Levy | director | C/O INNVERNESS MEDICAL INNOVATIONS, INC., 51 SAWYER ROAD, WALTHAM MA 02453 |
John Quelch | director | C/O INVERNESS MEDICAL INNOVATIONS INC, 51 SAWYER RD, WALTHAM MA 02453 |
Carol R Goldberg | director | C/O INVERNESS MEDICAL INNOVATIONS INC, 51 SAWYERS RD, WALTHAM MA 02453 |
From GuruFocus
By Alberto Abaterusso Alberto Abaterusso • 10-23-2016
By Vatalyst.com Vatalyst.com • 02-28-2012
By Vera Yuan Vera Yuan • 11-21-2014
By guruek guruek • 11-25-2010
By Vera Yuan Vera Yuan • 10-17-2014
By Vera Yuan Vera Yuan • 10-17-2014
By Canadian Value Canadian Value • 03-06-2015
By Alberto Abaterusso Alberto Abaterusso • 09-29-2017
By Vera Yuan Vera Yuan • 03-17-2015
By Alberto Abaterusso Alberto Abaterusso • 07-10-2017
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.